GPCR Latest Headlines

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Tue, 9-Jun 7:20 AM)

Structure Therapeutics Maintained at Buy as Analyst Highlights Best-in-Class Oral GLP-1 Profile and Keeps $145 Price Target Unchanged

at www.tipranks.com (Mon, 8-Jun 9:45 AM)

Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Cabaletta Bio (CABA) and Hinge Health, Inc. Class A (HNGE)

at www.tipranks.com (Mon, 8-Jun 9:20 AM)

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

at www.tipranks.com (Mon, 8-Jun 6:20 AM)

Aleniglipron Achieves Best-in-Class Oral GLP-1 Efficacy with Over 16% Weight Loss in Phase 2 Data—Low Discontinuation Rates Highlight Tolerability

Market Chameleon (Mon, 16-Mar 11:45 AM)

Aleniglipron Sets New Standard in Oral GLP-1 Weight Loss: Phase 2 Data Show Sustained Efficacy and Strong Safety

Market Chameleon (Mon, 16-Mar 7:30 AM)